NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Suzhou Otovia Therapeutics Co., Ltd.

Suzhou Otovia Therapeutics Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://otoviatx.com/

Last Round

VC Round

Jan 4, 2026

Company Overview

Suzhou Otovia Therapeutics Co., Ltd. is a biotechnology company that develops AAV-based gene therapies for the treatment of hearing loss and related neurodegenerative conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyadeno-associated virusAAVcongenital deafnessgenetic hearing lossOTOF geneinner ear therapygene replacementclinical stage biotechdual AAV platformneurodegenerative diseaseprecision medicinegenetic medicinehearing restorationbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Suzhou Otovia Therapeutics Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Suzhou Otovia Therapeutics Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Suzhou Otovia Therapeutics Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 4, 2026
AngelJan 1, 2022

Suzhou Otovia Therapeutics Co., Ltd. Investors

Notable investors and investment history

Suzhou Otovia Therapeutics Co., Ltd. investors
InvestorRounds
Dingxin CapitalVC Round
南京市创新投资集团有限责任公司VC Round

Suzhou Otovia Therapeutics Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Suzhou Otovia Therapeutics Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Suzhou Otovia Therapeutics Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Year Founded2022
Last FundingJan 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.